pharmaphorum6h
The rise and market race of anti-IL23p19 therapies in IBD: How ECCO 2025 readouts will shape the anti-interleukin landscape
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
News Medical on MSN5h
Unfolded protein response: A key regulator of intestinal health and disease
The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...
The Financial Express10h
Gut Health Guide | 7 in 10 people struggle with digestive issues—Why it matters and how to fix it
Gut health is about how well your body digests food, absorbs nutrients, and maintains a balance of good and bad bacteria.
ABIVAX Société Anonyme (NASDAQ:ABVX) Receives $38.67 Consensus PT from Analysts
ABIVAX Société Anonyme (NASDAQ:ABVX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven ratings firms that are presently covering the stock, Ratings reports. One ...
PipelineReview.com12h
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Preclinical Data Highlight TP-317’s Anti-Inflammatory, Epithelial Barrier-Protective Effects ...
The Nation Newspaper20h
HIV, HPV red flags fly over 2025 Valentine’s Day (2)
“The Tree Man was Dede Koswara, an Indonesian man who suffered from a rare genetic disorder called Epidermodysplasia ...
Science Daily19h
Ginger compound has potential to treat inflammatory bowel disease
Researchers have found a compound in ginger, called furanodienone (FDN), that selectively binds to and regulates a nuclear receptor involved in inflammatory bowel disease (IBD). While researchers have ...